(*) Products covered by valid patents in any country are not offered or supplied to these countries.
Samples for R&D use in the United States are available as permitted under 35 USC § 271 (e)(1)
PRODUCTS AT LATE STAGE OF DEVELOPMENT
Product Name / CAS No
Therapeutic Category
Availability
Regulatory Data
Pharmacopoeias
DRONEDARONE / 141626-36-0
Antiarrhythmic
Laboratory batches
TP
(**)
DULOXETINE HCL / 136434-34-9
Antidepressant
Validation batches
EDMF, USDMF
(**)
ENTACAPONE / 130929-57-6
Antiparkinsonian
Validation batches
EDMF, USDMF
Ph. Eur. 7 , USP 34
IRBESARTAN / 138402-11-6
Cardiovascular
Validation batches
EDMF, USDMF
Ph. Eur. 7 , USP 34
MONTELUKAST / 151767-02-1
Anti asthmatic
Validation batches
TP
(**)
OLMESARTAN / 144689-63-4
Cardiovascular Angiotensin II antagonist
Validation batches
EDMF
PREGABALIN / 148553-50-8
Antiepileptic
Validation batches
EDMF
(**)
RABEPRAZOLE SODIUM / 117976-90-6
Anti ulcerative
Validation batches
EDMF,USDMF
(**)
TELMISARTAN / 144701-48-4
Cardiovascular
Validation batches
EDMF, USDMF
Ph. Eur. 7, USP 34
(**) Products covered by valid patents in any country are not offered or supplied to these countries.
Product currently under patent protection could be available only for R&D purposes, if this is allowed by local laws.
Samples for R&D use in the United States are available as permitted under 35 USC § 271 (e)(1)